New Carcinomas Findings from University of Texas MD Anderson Cancer Center Reported (Concordance Between Pathologists and Between Specimen Types In Detection of Her2-low Breast Carcinoma By Immunohistochemistry)

MLA

“New Carcinomas Findings from University of Texas MD Anderson Cancer Center Reported (Concordance Between Pathologists and Between Specimen Types In Detection of Her2-Low Breast Carcinoma By Immunohistochemistry).” Women’s Health Weekly, July 2024, p. 516. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.801305906&authtype=sso&custid=ns315887.

APA

New Carcinomas Findings from University of Texas MD Anderson Cancer Center Reported (Concordance Between Pathologists and Between Specimen Types In Detection of Her2-low Breast Carcinoma By Immunohistochemistry). (2024, July 18). Women’s Health Weekly, 516.

Chicago

Women’s Health Weekly. 2024. “New Carcinomas Findings from University of Texas MD Anderson Cancer Center Reported (Concordance Between Pathologists and Between Specimen Types In Detection of Her2-Low Breast Carcinoma By Immunohistochemistry),” July 18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.801305906&authtype=sso&custid=ns315887.